ARS Pharmaceuticals, Inc. (SPRY)
4.24
-0.32
(-7.02%)
USD |
NASDAQ |
Oct 09, 16:00
4.24
0.00 (0.00%)
After-Hours: 16:11
ARS Pharmaceuticals Max Drawdown (5Y) : 95.20% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 95.20% |
| August 31, 2026 | 95.20% |
| July 31, 2026 | 95.20% |
| June 30, 2026 | 95.20% |
| May 31, 2026 | 95.20% |
| April 30, 2026 | 95.20% |
| March 31, 2026 | 95.20% |
| February 28, 2026 | 95.20% |
| January 31, 2026 | 95.20% |
| December 31, 2025 | 95.20% |
| November 30, 2025 | 95.20% |
| October 31, 2025 | 95.20% |
| September 30, 2025 | 95.20% |
| August 31, 2025 | 95.20% |
| July 31, 2025 | 95.20% |
| June 30, 2025 | 95.20% |
| May 31, 2025 | 95.20% |
| April 30, 2025 | 95.20% |
| March 31, 2025 | 95.20% |
| February 28, 2025 | 95.20% |
| January 31, 2025 | 95.20% |
| December 31, 2024 | 95.20% |
| November 30, 2024 | 95.20% |
| October 31, 2024 | 95.20% |
| September 30, 2024 | 95.20% |
| Date | Value |
|---|---|
| August 31, 2024 | 95.20% |
| July 31, 2024 | 95.20% |
| June 30, 2024 | 95.20% |
| May 31, 2024 | 95.20% |
| April 30, 2024 | 95.20% |
| March 31, 2024 | 95.20% |
| February 29, 2024 | 95.20% |
| January 31, 2024 | 95.20% |
| December 31, 2023 | 95.20% |
| November 30, 2023 | 95.20% |
| October 31, 2023 | 95.20% |
| September 30, 2023 | 95.20% |
| August 31, 2023 | 95.20% |
| July 31, 2023 | 95.20% |
| June 30, 2023 | 95.20% |
| May 31, 2023 | 95.20% |
| April 30, 2023 | 95.20% |
| March 31, 2023 | 95.20% |
| February 28, 2023 | 95.20% |
| January 31, 2023 | 95.20% |
| December 31, 2022 | 95.20% |
| November 30, 2022 | 95.20% |
| October 31, 2022 | 95.20% |
| September 30, 2022 | 95.20% |
| August 31, 2022 | 95.20% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Capricor Therapeutics, Inc. | 91.80% |
| Sionna Therapeutics, Inc. | -- |
| Nektar Therapeutics | 99.39% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Ardelyx, Inc. | 95.65% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -27.72 |
| Beta (5Y) | 0.8472 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.10% |
| Historical Sharpe Ratio (5Y) | -0.2785 |
| Historical Sortino (5Y) | -0.4557 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.29% |